Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,602 public trials 545 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Active, Not Recruiting

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM

NCT07084896

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • 238995 Atlanta, Georgia, United States
  • 240593 Boston, Massachusetts, United States
  • 251164 Grand Rapids, Michigan, United States
  • 239015 Madison, Wisconsin, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study of AT-02 in Subjects With Systemic Amyloidosis.

NCT05951049

Conditions
Amyloidosis, Amyloidosis; Systemic, Immune System Diseases, +10 more
Locations
  • Kansas City Kansas City, Kansas, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • OHSU (Oregon Health & Science University) Portland, Oregon, United States
  • Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT04126200

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Indianapolis, Indiana, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Grand Rapids, Michigan, United States
View all 38 locations
View Trial Details

Related conditions